mProX™ Human DYRK2 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Nancy
Verified Customer
Jessica
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 NOTCH1 protein levels are modulated by DYRK2.
After transfecting HEK-293T cells with the designated plasmids, the cells were lysed 48 hours later. Immunoblotting was used to assess the expression of proteins.
Ref: Morrugares, Rosario, et al. "Phosphorylation-dependent regulation of the NOTCH1 intracellular domain by dual-specificity tyrosine-regulated kinase 2." Cellular and Molecular Life Sciences 77 (2020): 2621-2639.
Pubmed: 31605148
DOI: 10.1007/s00018-019-03309-9
Research Highlights
From yeast to mammals, dual-specificity tyrosine-regulated kinases (DYRKs) have been conserved throughout evolution. A growing body of research has demonstrated the significance of DYRKs in survival and cell cycle regulation.
Yoshida, Saishu, and Kiyotsugu Yoshida. "Multiple functions of DYRK2 in cancer and tissue development." FEBS letters 593.21 (2019): 2953-2965.
Pubmed:
31505048
DOI:
10.1002/1873-3468.13601
These findings demonstrated that DYRK2 expression in HCC tumor tissues was downregulated, which may have encouraged the growth of HCC cells. Furthermore, in HCC, decreased DYRK2 expression was linked to a poor prognosis and oxaliplatin resistance.
Zhang, Xiubing, et al. "Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma." Pathology-Research and Practice 212.3 (2016): 162-170.
Pubmed:
26804244
DOI:
10.1016/j.prp.2016.01.002